Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
To characterize the molecular and cell biology of the tumor cells in lymphoma. The mechanism of monoclonal antibody treatment by rituximab or epratuzumab will also be examined.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion Criteria:Non-Hodgkin's Lymphoma Patients Receiving Antibody Treatment
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal